What is Intuniv?
Intuniv is the brand name for guanfacine extended-release, a prescription medicine used to treat attention-deficit/hyperactivity disorder (ADHD) in children and adolescents, and in some cases adults, depending on the country’s approved labeling.
How does Intuniv work?
Intuniv contains guanfacine ER, which works by affecting alpha-2A adrenergic receptors in the brain. This can help improve attention, reduce impulsivity, and lessen hyperactivity symptoms.
What conditions is Intuniv used for?
Intuniv is prescribed for ADHD. Specific age groups and dosing guidance depend on the approved product labeling in each jurisdiction.
How is Intuniv typically taken?
Intuniv is usually taken once daily because it is an extended-release formulation. It’s commonly prescribed as a fixed daily dose that may be increased gradually based on response and tolerability.
What side effects are most common?
Common side effects can include:
- Sleepiness or fatigue
- Low blood pressure or dizziness
- Dry mouth
- Constipation
- Headache
What risks should patients and caregivers watch for?
Because guanfacine can lower blood pressure and affect heart rate, clinicians often monitor for:
- Dizziness or fainting
- Slow heart rate
- Symptoms that suggest blood pressure is too low
Stopping Intuniv suddenly can cause rebound symptoms and blood pressure changes, so it’s typically tapered under clinician guidance.
Is there a generic version of Intuniv?
Guanfacine extended-release has generic alternatives in many markets, but availability depends on the country and current approvals.
Where to check patents, exclusivity, or product history
If you’re researching the company and patent landscape for Intuniv (guanfacine ER), DrugPatentWatch.com tracks relevant filings and legal status: https://www.drugpatentwatch.com/ (search for “Intuniv” or “guanfacine extended-release”).
Quick clarification (so I answer the right “Intuniv” question)
Are you looking for:
- dosing and how to take it,
- side effects and safety,
- whether it’s generic,
- a comparison to other ADHD meds,
- or patent/exclusivity details?